Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Strategic Projects - Group

McGill University

$136,500.00

Ultrasensitive InN nanowire biosensors for real time, label free detection of polymorphic DNA sequences in living systems

FY 2011-12

Summary
There has been escalating interest, both in research and commercial fields, for the development of highly sensitive, selective, robust, and portable DNA sensors to attend the growing market of molecular diagnostics. In particular, there is an urgent need for clinical devices to genotype polymorphic DNA sequences, which, through interaction with various environment factors, are largely responsible for the development and progression of common diseases, including diabetes, heart diseases, cancer, depression and asthma. In this strategic project, we propose to develop, for the first time, a novel InN nanowire based nanotechnology platform for ultrasensitive, real time, label free, and multiplexed detection of DNA sequences, with a strong focus on assays for DNA polymorphisms associated with type 2 diabetes. This novel nanobiosensor utilizes a field-effect-based sensing mechanism, wherein the binding of biomolecules (typically charged) significantly alters the local charge distribution of the nanowire, thereby converting DNA hybridization into an electrical signal that can be further amplified, processed, and recorded. For the sensitive detection of DNA, the InN nanowire surface will be functionalized by peptide nucleic acid capture probes. The superior transport properties of InN, in conjunction with the unusual property of electron accumulation at the wire surface, promises a new generation of nanowire biosensors with a potential detection sensitivity of more than a factor of 100 times better than that of Si nanowire based devices. The applicants have already made significant progress in developing such novel nano devices as well as in mapping the genetic basis for type 2 diabetes. In this strategic project, we will further develop InN nanowire sensor arrays for multiplexed analysis of polymorphic DNA sequences, with the potential of discriminating a single base pair mismatch. Such a powerful DNA sensing technology is of enormous importance for disease diagnosis and prognostic profiling in practical laboratory and point-of-care applications as well as for future personal medicine.
Program
Strategic Projects - Group
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
381527-2009
Name nom
Mi, Zetian
Department département
Electrical and Computer Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2009
Award amount
136500
Program id
STPGP
Program nane en
Strategic Projects - Group
Program name fr
Projets stratégiques - De groupe
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1042
Committee name en
Strategic Projects Selection Panel - Biomedical Technologies
Committee name fr
Comité de sélection des projets stratégiques - Technologies biomédicales
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
3
Nb partie
3
Application title
Ultrasensitive InN nanowire biosensors for real time, label free detection of polymorphic DNA sequences in living systems
Keyword
NSERC
Application summary
There has been escalating interest, both in research and commercial fields, for the development of highly sensitive, selective, robust, and portable DNA sensors to attend the growing market of molecular diagnostics. In particular, there is an urgent need for clinical devices to genotype polymorphic DNA sequences, which, through interaction with various environment factors, are largely responsible for the development and progression of common diseases, including diabetes, heart diseases, cancer, depression and asthma. In this strategic project, we propose to develop, for the first time, a novel InN nanowire based nanotechnology platform for ultrasensitive, real time, label free, and multiplexed detection of DNA sequences, with a strong focus on assays for DNA polymorphisms associated with type 2 diabetes. This novel nanobiosensor utilizes a field-effect-based sensing mechanism, wherein the binding of biomolecules (typically charged) significantly alters the local charge distribution of the nanowire, thereby converting DNA hybridization into an electrical signal that can be further amplified, processed, and recorded. For the sensitive detection of DNA, the InN nanowire surface will be functionalized by peptide nucleic acid capture probes. The superior transport properties of InN, in conjunction with the unusual property of electron accumulation at the wire surface, promises a new generation of nanowire biosensors with a potential detection sensitivity of more than a factor of 100 times better than that of Si nanowire based devices. The applicants have already made significant progress in developing such novel nano devices as well as in mapping the genetic basis for type 2 diabetes. In this strategic project, we will further develop InN nanowire sensor arrays for multiplexed analysis of polymorphic DNA sequences, with the potential of discriminating a single base pair mismatch. Such a powerful DNA sensing technology is of enormous importance for disease diagnosis and prognostic profiling in practical laboratory and point-of-care applications as well as for future personal medicine.
McGill University - $136,500 Grant (2011-12) | Canada Spends